Clinical trial Recruiting at 1 site Interventional

Comparing NeuroVision to standard neuromonitoring during spinal surgery

Official title: NeruoVision Versus Standard Hospital Neuromonitoring, Influence on the Rate of Neurologic Injury Following Spine Surgery? A Randomized Controlled Trial

Run by Rush University Medical Center · NCT04639297 · Data updated 2026-11-12

This study is testing if a new monitoring system called NeuroVision can help prevent nerve injuries during spinal surgery better than the standard monitoring methods.

Quick facts

Study typeInterventional
SexAll
Enrollment148 (estimated)
SponsorRush University Medical Center
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedSeptember 28, 2020
Main results expectedDecember 20, 2027
Study endsDecember 20, 2027
Registry record updatedApril 7, 2026
Trial IDNCT04639297 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients scheduled for primary single or multilevel lateral spinal surgery due to degenerative conditions.

Probably not a fit

Patients with active infections, a history of malignancy, or recent spinal traumatic injuries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of NeuroVision® intraoperative neuromonitoring (IONM) compared to conventional hospital-based IONM in patients undergoing lateral spinal surgery for degenerative conditions. Participants will be randomly assigned to receive either NeuroVision® IONM or standard IONM during their surgery. The study will assess the incidence of new-onset neurological injuries postoperatively, providing insights into the safety and efficacy of the NeuroVision® system. By utilizing real-time monitoring, the trial seeks to enhance surgical outcomes and minimize risks associated with spinal procedures.

Why it matters

Potential benefit: If successful, this study could lead to improved neurological outcomes for patients undergoing spinal surgery.

How similar studies have gone: Previous studies have shown promise in the use of intraoperative neuromonitoring, but the specific application of NeuroVision® is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing a primary single or multilevel lateral spinal surgery procedures for degenerative pathology Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, central stenosis, foraminal stenosis herniated nucleus pulposus, degenerative disc disease, spondylosis, and osteophytic complexes
* Patients able to provide informed consent

Exclusion Criteria:

* Active infection
* Active or history of malignancy
* Spinal traumatic injury within the past 2 years

Where it's running

  • Rush University Medical Center
    Chicago, Illinois, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.